ReviewDer Orthopade2017
[Reconstruction of osseous defects using the Masquelet technique].
Review in Der Orthopade, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 12 citations in OpenAlex.
- PMMA-induced membranous angiogenesis accelerates wound healing in refractory diabetic foot ulcers: A comparative cohort study.JPRAS open · 2026Article
- [Endoprosthetic replacement following intercalary resection].Der Orthopade · 2019Review
- The Masquelet technique in traumatic loss of the talus after open lateral subtalar dislocation-A case report.International journal of surgery case reports · 2019Article
- Clinical and Research Approaches to Treat Non-union Fracture.Current osteoporosis reports · 2018Review
- [Callus distraction and bone transport in the treatment of bone defects].Der Orthopade · 2017Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Masquelet procedure or induced membrane technique presents a treatment option for relatively large osseous defects, e.g. after trauma, tumour resection or osteomyelitis even in the presence of unfavourable soft tissues. Initially developed at the end of the last century by the French surgeon Masquelet, the technique relies on a bioactive membrane that forms a foreign body reaction around a cement spacer. This spacer is implanted in the residual defect after rigorous debridement of bone and soft tissue during a first-stage procedure. A second-stage intervention is performed 1-2 months later with removal of the spacer under preservation of the membrane that has since formed around the cement. The membrane acts as an internal bioreactor exerting its effect via a rich vascularization and secretion of growth and differentiation factors. The void within the membrane is filled with an autologous cancellous graft. After adequate stabilisation using standard techniques, a gradual corticalisation of the graft can be observed over the duration of several months, with remodelling in the long-term course.The following article describes the original technique, our preferred approach including indication, surgical technique and postoperative follow-up. Additionally, the biological background and clinical tips and tricks are presented.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.